Prucalopride Succinate Tablet
Product Images NDC 70069-822

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Prucalopride Succinate (NDC 70069-822). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Ee246af0 B06a 45e2 8efa 704918359d36 01)

Chemical structure of prucalopride succinate, an active pharmaceutical ingredient used in oral tablet form. The diagram shows the molecular arrangement including a chlorinated aromatic ring, amide and amine groups, and the succinate moiety.*

FDA Label Image

Image (Ee246af0 B06a 45e2 8efa 704918359d36 02)

Label for Prucalopride Tablets 1 mg oral tablets by Somerset Therapeutics LLC. The package contains 30 tablets with a usual dose of one tablet once daily. Storage instructions and manufacturer details are included, along with barcodes and regulatory information.*

FDA Label Image

Image (Ee246af0 B06a 45e2 8efa 704918359d36 03)

Label for Prucalopride Tablets 2 mg oral tablets, with 30 tablets per package. Manufactured for Somerset Therapeutics, LLC, Somerset, NJ, and made in Malta. The label includes storage instructions, dosage strength, manufacturer information, and barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.